Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda Huff, Neeha Zaidi, Ludmila Danilova et al.|Nature Communications|2026Cited by 15
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trialHejia Wang, Neeha Zaidi, Amanda L. Huff et al.|Nature Communications|2026Cited by 1